Pfizer should have different top-selling drugs in 2030 with a heavier focus on oncology. The drugmaker should be more efficient and growing modestly. Pfizer will likely still be paying a great ...

In the wake of Trump’s global trade war, can the World Trade Organization reclaim its role as guardian of free trade?